Lipids and lipid-activated vitamins in chronic cholestatic diseases.
Primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune cholangiopathy are cholestatic liver diseases of unknown cause. Destruction of small to medium bile ducts (in primary biliary cirrhosis and autoimmune cholangiopathy) and large bile ducts (in primary sclerosing cholangitis) leads to progressive cholestasis, liver failure and end-stage liver disease. A variety of abnormalities in lipid metabolism have been described in primary biliary cirrhosis, and range from alterations in serum lipid levels and lipoprotein subsets to deranged metabolism of cholesterol. Progressive cholestasis and, consequently, decreased small intestinal bile acid concentrations in these cholestatic liver disease can also lead to impaired absorption of fats and fat-soluble vitamins, resulting in steatorrhea and deficiencies in vitamins A, D, E, and K. This article focuses on abnormalities in lipid metabolism in primary biliary cirrhosis and primary sclerosing cholangitis, and on lipid-activated vitamin deficiencies in these disorders.
Kowdley
K V
KV
Division of Gastroenterology and Hepatology, University of Washington School of Medicine, Seattle, Washington 98195, USA. kkowdley@u.washington.edu
D001361:Avitaminosis / Q000378:metabolism; D015209:Cholangitis, Sclerosing / Q000378:metabolism; D002779:Cholestasis / Q000378:metabolism*; D002908:Chronic Disease; D005234:Fatty Liver / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism; D008105:Liver Cirrhosis, Biliary / Q000378:metabolism; D008286:Malabsorption Syndromes / Q000378:metabolism; D014801:Vitamin A / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism; D014810:Vitamin E / Q000378:metabolism; D014812:Vitamin K / Q000378:metabolism; D014815:Vitamins / Q000378:metabolism*
D014815:Vitamins; D014801:Vitamin A; D014812:Vitamin K; D014807:Vitamin D; D014810:Vitamin E